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Protein translocation across the cytoplasmic membrane of
Escherichia coli is mediated by translocase, a complex of a pro-
tein-conducting channel, SecYEG, and a peripheral motor
domain, SecA. SecYEGhas beenproposed to constitute an aque-
ous path for proteins to pass themembrane in an unfolded state.
To probe the solvation state of the active channel, the polarity
sensitive fluorophore N-((2-(iodoacetoxy)ethyl)-N-methyl)
amino-7-nitrobenz-2-oxa-1,3-diazole was introduced at
specific positions in the C-terminal region of the secretory
protein proOmpA. Fluorescence measurements with defined
proOmpA-DHFR translocation intermediates indicate
mostly a water-exposed environment with a hydrophobic
region in the center of the channel.
Translocase is a protein complex that mediates the secre-
tion of preproteins across the bacterial cytoplasmic mem-
brane. It consists of the membrane-integral heterotrimeric
SecYEG complex (1), which forms a transmembrane pro-
tein-conducting channel (PCC),2 and the peripherally asso-
ciated cytosolic ATPase SecA (2, 3), which functions as a
motor protein. The PCC is evolutionarily conserved and is
found in all domains of life. It mediates both the transport of
secretory proteins across the membrane, as well as the inser-
tion of membrane proteins into the membrane (4). Secretory
proteins are synthesized as precursors (preproteins) with a
characteristic N-terminal signal sequence that is recognized
by translocase (5). Preproteins are kept translocation-com-
petent during synthesis (6) and are targeted to the PCC-
bound SecA (7–9) by the cytosolic chaperone SecB (10). Suc-
cessive rounds of binding and hydrolysis of ATP by SecA
result in the stepwise translocation of the unfolded prepro-
tein through the PCC (11–13). In addition, the proton
motive force facilitates translocation by an unknown mech-
anism (11, 14).
A critical requirement for the PCC is to maintain the mem-
brane barrier for ions and other small solutes both under idle
and active conditions. This is particularly important in bacteria
and Archaea as the cytoplasmic membrane plays a key role in
proton and sodium ion-based energy transduction. Only
recently, an understanding is emerging how the membrane
integrity is preserved during protein translocation. A cryo-elec-
tron microscopy study indicates that the active PCC bound to
the ribosome consists of a dimer of SecYEG (15, 16), whereas
both structural and biochemical studies indicate an oligomeric,
possibly dimeric, assembly of the SecA-bound PCC (17–19).
X-ray structural analysis indicates that the SecY protein of a
single SecYEG complex has a clamshell-like shape that encom-
passes a central channel. The channel in this monomeric com-
plex is constricted and closed at the center by a ring of hydro-
phobic amino acid residues, termed the pore. In addition,
a periplasmic re-entrance loop (TM2a) closes the pore at the
extracellular side like a plug. The pore and the plug domains
have been proposed to seal the channel under idle conditions
(20).
The plug is a flexible structure that can be cross-linked to
SecE at the periplasmic membrane interface peripheral to the
translocation pore (21). It has been proposed that the channel is
opened upon the insertion of the signal sequence forming a
wedge at the membrane lateral opening of the clamshell. The
recently proposed peristalsis model suggests that channel
opening is induced by SecA (or the ribosome) rather than the
signal sequence (22). In this model, SecA controls the juxtapo-
sitioning of two SecYEG protomers of a dimeric complex with
their lateral gates facing each other (15, 16). In eithermodel, the
enlargement of the pore will result in a destabilization of the
plug, which is subsequently displaced, enabling the vectorial
membrane passage of unfolded preproteins. Biochemical stud-
ies indeed show that the plug domain is more readily cross-
linked to SecE in the presence of a proOmpA preprotein (23).
However, the role of the plug as a sealing entity seems question-
able, as it is not essential for viability and preprotein transloca-
tion (24, 25). Recent evidence suggests that in the absence of a
plug, other periplasmic loops of SecY substitute for the plug
domain to seal the periplasmic exit site (26).
Cross-linking experiments have shown that a ribosome-
bound proOmpA translocation intermediate preferentially
localizes in the neighborhood of pore residues at the center of
the PCC, while minimizing contact with the remainder of the
structure (27). A close association of the hydrophobic porewith
the preprotein may provide a way to prevent ions and solutes
from leaking through the channel (1, 20, 27). Indeed, in a recent
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MD simulation, few water molecules and no ions seemed to
permeate the Sec61 channel in the presence of a polypeptide
chain (28). However, the presence of a functional hydrophobic
constriction in the translocation channel in its active state
remains to be demonstrated experimentally, because previous
fluorescent studies on the polarity of the active PCC in endo-
plasmic reticulummembranes argue that the channel is hydro-
philic throughout (29, 30). Moreover, fluorophores positioned
along the PCC spanning part of the nascent polypeptide chain
were found to be accessible to bulky water-soluble quenchers,
giving rise to the hypothesis that the active PCC forms a large
aqueous channel with a diameter of up to 60 Å (31). Instead, a
PCC sealing function in the endoplasmic reticulum lumen has
been attributed to the chaperone BiP (32), whereas at the cyto-
solic face of themembrane a tight seal would be provided by the
ribosome (30, 32–34).
In Escherichia coli, most secretory proteins translocate in a
post-translational manner. It is unknown if any of the PCC
ligands, such as SecA, contribute to sealing of the translocation
channel. Previous studies have demonstrated that disulfide-
bridged loops of up to 13 amino acids introduced into the pre-
protein proOmpA do not block translocation provided that a
proton motive force is present (35, 36). The translocation of
such bulky structures requires a high flexibility of the channel,
and the pore needs to widen considerably while maintaining a
close seal with the preprotein.
To examine themolecular environment of the PCC of E. coli,
while active in SecA-mediated post-translational translocation,
we have inserted the environmentally sensitive probe N-((2-
(iodoacetoxy)ethyl)-N-methyl)amino-7-nitrobenz-2-oxa-1,3-
diazole (NBD) at defined positions inside the channel, while
conjugated to a proOmpA-DHFR translocation intermediate
(37, 38). NBD was conjugated to the protein by means of cys-
teine-scanningmutagenesis and thiol chemistry. By varying the
position of NBD along the chain of the translocation interme-
diate, we aimed at analyzing the polarity at evenly spaced posi-
tions throughout the channel. Our results demonstrate that a
hydrophobic locality exists in the active PCC that corresponds
to the central region of the translocation channel.
EXPERIMENTAL PROCEDURES
Materials—SecA (39), SecB (40), and proOmpA-DHFR (37,
38, 41) were overexpressed, isolated, and purified as described.
Overexpression of SecYEG and subsequent isolation of
inverted innermembrane vesicles (IMVs)were done essentially
as described (42). Chemicals used were reagent grade or better.
Premixed acrylamide/bisacrylamide 37.5:1 was from Bio-Rad.
N-((2-(Iodoacetoxy)ethyl)-N-methyl)amino-7-nitrobenz-2-oxa-
1,3-diazole, Oregon Green 488maleimide, fluorescein-5-male-
imide, and tris-(2-carboxyethyl)phosphine hydrochloride were
from Invitrogen. Absolute ethanol and protease K were from
Merck. 1,4-Dithiothreitol (DTT) was from Roche Applied Sci-
ence. 4-Amino-N10-methylpteroyl-L-glutamic acid (metho-
trexate), -nicotinamide adenine dinucleotide 2-phosphate
reduced tetrasodium salt (-NADPH), nucleotides, and
sodium tetrathionate dihydrate (Na2S4O6) were from Sigma.
Strains and Plasmids—The strains and plasmids used in this
study are listed in Table 1. E. coli strain SF100 was used for
overexpression of wild-type and mutant SecYEG, which con-
tained a hexahistidine tag at the N terminus of SecY. E. coli
strain DH5 was used for overexpression of proOmpA-DHFR.
All plasmids contained the gene of interest behind the isopropyl
1-thio--D-galactopyranoside-inducible T7 promoter, as well
as an ampicillin resistance marker. The positions of proOmpA
correspond to themature proteinminus the signal sequence for
consistency (38).
ProOmpA-DHFR is a fusion construct of E. coli proOmpA
and murine DHFR (43). The latter contained an endogenous
cysteine (Cys7) at position Cys334 in the proOmpA-DHFR pro-
teins. This aminoacyl residue was substituted for a serine using
TABLE 1
Overview of strains and plasmids used
Strain/plasmid Characteristic Source
E. coli DH5 supE44, lacU169 (80lacZM15) hsdR17, recA1, endA1, gyrA96 thi-1, relA1 54
E. coli SF100 F, lacX74, galE, galK, thi, rpsL, strA phoA(pvuII), ompT 55
pET610 SechYnEG 56
pET2311 SechYn(F67C)EG; derived from pET610 J. de Keyzer, unpublished data
pET2520 SechYn(S282C)EG; derived from pET607 57
pET401 DHFR(C7S) E. O. van der Sluis, unpublished data
pEK27 proOmpA(S66C;C290S;C302S)-DHFR E. O. van der Sluis, unpublished data
pET75 proOmpA(S245C;C290S;C302S)-DHFR This study
pET76 proOmpA(S266C;C290S;C302S)-DHFR This study
pET77 proOmpA(S275C;C290S;C302S)-DHFR This study
pET78 proOmpA(S282C;C290S;C302S)-DHFR This study
pET79 proOmpA(C302S)-DHFR This study
pET80 proOmpA(C290S)-DHFR This study
pET81 proOmpA(G315C;C290S;C302S)-DHFR This study
pET82 proOmpA(C290S;C302S)-DHFR This study
pEK501 proOmpA(S245C;C290S;C302S)-DHFR(C334S); derived from pET75 This study
pEK502 proOmpA(S266C;C290S;C302S)-DHFR(C334S); derived from pET76 This study
pEK503 proOmpA(S275C;C290S;C302S)-DHFR(C334S); derived from pET77 This study
pEK504 proOmpA(S282C;C290S;C302S)-DHFR(C334S); derived from pET78 This study
pEK505 proOmpA(C302S)-DHFR(C334S); derived from pET80 This study
pEK506 proOmpA(C290S)-DHFR(C334S); derived from pET81 This study
pEK507 proOmpA(G315C;C290S;C302S)-DHFR(C334S); derived from pET79 This study
pEK508 proOmpA(C290S;C302S)-DHFR(C334S); derived from pET82 This study
pEK509 proOmpA(C290S;C302S;I300C)-DHFR(C334S); derived from pEK508 This study
pEK510 proOmpA(C290S;C302S;D301C)-DHFR(C334S); derived from pEK508 This study
pEK511 proOmpA(C290S;C302S;L303C)-DHFR(C334S); derived from pEK508 This study
pEK522 proOmpA(C290S;C302S;E310C)-DHFR(C334S); derived from pEK508 This study
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standard cloning techniques. The SalI/HindIII restriction frag-
ment of pET401, containing cysteine-less DHFR, was cloned
into vectors pET75-pET82, creating vectors pEK501-pEK508.
Mutations I300C,D301C, and L303Cwere introduced into cys-
teine-less pEK508, creating pEK509, pEK510, and pEK511,
respectively (Table 1).
Fluorescent Labeling of Proteins—ProOmpA-DHFR was
denatured in buffer A: 50 mM Tris-HCl, pH 7.4, 8 M urea at a
final concentration of 0.1 mg/ml. Thiols were reduced with 25
M tris-(2-carboxyethyl)phosphine hydrochloride for 30min at
room temperature. Labeling was performed with 250 M of
fluorophore for 30 min (fluorescein, Oregon Green) or 2 h
(NBD) at room temperature under constant stirring. Reactions
were quenched with 2.5 mM DTT for 10 min at room temper-
ature, and free probe was removed by precipitation of the pro-
tein with 10% (w/v) trichloroacetic acid. The protein was resus-
pended in 1:10 of the labeling volume of buffer A, and aliquots
were flash-frozen with liquid nitrogen and stored at 80 °C.
Labeling was analyzed by 12% SDS-PAGE and imaged using a
Lumi-imager F1 (RocheApplied Science), with a bandpass filter
at 520 nm (20 nm).
In Vitro Translocation Assay—The activity of IMVs was ana-
lyzed by means of a standard translocation and protease pro-
tection assay. ProOmpA-DHFR (37, 38) was used as a substrate,
which optionally contained a fluorescent label conjugated to a
unique cysteine in the proOmpA moiety. Standard transloca-
tion reactions were performed in a total volume of 50 l. Fold-
ing of the DHFR domain was induced by diluting the
proOmpA-DHFR (0.5 mg/ml), denatured in buffer A, 25-fold
into a buffer containing 50 mM Hepes-KOH, pH 7.6, 30 mM
KCl, 2 mM DTT, 18 g/ml SecB, 1 mM NADPH, and 50 M
methotrexate, with a final volume of 25 l. The mixture was
incubated for 5min on ice, another 5min at 37 °C, and stored at
4 °C. The folding mixture was then added to 25 l of the trans-
location buffer and kept at 4 °C. The translocation buffer con-
tained 50mMHepes-KOH, pH 7.6, 30mMKCl, 5mMMgCl2, 10
mM DTT, 0.5 mg/ml bovine serum albumin, 200 g/ml IMVs,
20g/ml SecA, 18g/ml SecB, 1mMNADPHand 50Mmeth-
otrexate and optionally 20 mM creatine phosphate and 20
g/ml creatine kinase. Typically, 0.5 g of proOmpA-DHFR
was used in the translocation assay. Reactions were started by
the addition of 2 mM of nucleotide in 100mMTris-HCl, pH 8.0,
and the mixture was incubated for 30 min at 37 °C. Thereafter,
when indicated, samples were digested for 15 min with 0.1
mg/ml protease K on ice, and proteolysis was terminated by the
addition of 10% trichloroacetic acid and further incubation for
30 min at 4 °C. Samples were centrifuged in a table-top centri-
fuge for 30 min at 4 °C, washed with ice-cold acetone, and
resuspended in SDS sample buffer. After 12% SDS-PAGE,
labeled protein was visualized in gel with a Lumi-imager F1
(Roche Applied Science), using a bandpass filter at 520 nm.
Fluorescence Assay—Spectrophotometric assays were per-
formed in a total volume of 150 l, by scaling up the standard
translocation reaction three times but leaving out the energy-
regenerating systemof creatine kinase/creatine phosphate. The
reaction mixture was incubated for 5 min, and started by
the addition of 2mM nucleotide in 100mMTris-HCl, pH 8.0. The
reaction was followed in time for 10 min on an Aminco-
Bowman series II spectrophotometer. Measurements were
performed at 37 °C, using a 4 nm slit width. F/F0 was calculated
by dividing the average emission intensity after addition of
nucleotide by the average intensity before addition of nucleo-
tide at 530 nm (2 nm), both after subtraction of the cysteine-
less sample.
DisulfideCross-linkAssay—The standard translocation reac-
tionwas scaled up five times and performed in a total volume of
250l, in the absence of DTT. After translocation for 30min at
37 °C, the reactions were cross-linked by the addition of 0.5mM
tetrathionate or received 10 mM DTT as a control. Incubation
was for 30min at 37 °C. To remove nontranslocated preprotein,
the reaction mixture was centrifuged through 200 l of buffer
B: 50 mM Tris-HCl, pH 8.0, 0.2 M sucrose, 50 mM KCl, 1 mM
NADPH and 50 M methotrexate in a Beckman Airfuge at
210,000  g for 30 min at room temperature. The pellet was
resuspended into nonreducing SDS-PAGE sample buffer, sep-
arated on 7.5% SDS-PAGE, and blotted according to standard
laboratory techniques, using a Bio-Rad semi-dry blotting sys-
tem. Blots were developed with polyclonal antibodies against
proOmpA or SecY and an alkaline phosphatase assay and
imaged on a Lumi-imager F1 (Roche Applied Science).
Miscellaneous—Protein determinations were performed by
means of the Lowry method, using the Protein DC assay (Bio-
Rad) and bovine serum albumin as a standard. The enzyme
activity of DHFR was measured using a spectrophotometric
NADPH oxidation assay (37).
RESULTS
Overexpression of ProOmpA-DHFRandLabeling of Cysteines—
To generate in vitro defined translocation intermediates
trapped inside the PCC, a fusion protein of proOmpA with
DHFR was used as a model secretory protein. Upon the folding
of the DHFRmoiety, a stable translocation intermediate can be
obtained after translocation of the proOmpA-DHFR into inner
membrane vesicles (IMVs) (37). In the folded DHFR, the
endogenous cysteine (Cys7) is not accessible to fluorescent
maleimides but becomes readily labeled upon urea denatur-
ation of the protein. Because labeling of this position interferes
with folding of DHFR, a proOmpA-DHFR mutant was used in
which Cys7 of DHFR was replaced by a serine. The C7S (C334S
in the proOmpA-DHFR protein) substitution did not affect the
folding properties of the enzyme when refolded from a urea-
denatured state, as verified by NADPH oxidation (data not
shown) and protease protection (see below). In a previous
study, the C7S/S42C/N49C triple mutant of DHFR was
reported to be highly sensitive to protease and not able to bind
the substrate analog methotrexate (43). Therefore, the muta-
tions at positions 42 and 49 seem to infer the labile phenotype.
Next, we introduced unique cysteines in the C-terminal tail of
the cysteine-less proOmpA(C290S, C302S) fused to
DHFR(C334S), further referred to as cysteine-less proOmpA-
DHFR (Fig. 1). This region of proOmpA was previously found
to cross-link to SecY when trapped in the PCC as a transloca-
tion intermediate (38). Therefore, this region must be in prox-
imity to SecY.
All the proOmpA-DHFR mutants were overexpressed at
high levels and purified to homogeneity. To verify the accessi-
SecYEG Channel Polarity
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bility of the newly introduced cysteines, urea-denatured pro-
teins were labeled with the Oregon Green 488 maleimide (OG)
fluorophore. This reagent is very reactive toward thiols and
efficiently labeled all the single cysteine proOmpA-DHFR pro-
teins with essentially no signal with the cysteine-less
proOmpA-DHFR protein (supplemental Fig. 1, A and B). A
second incubation with the spectrally distinct fluorophore
Texas Red C2-maleimide indicated a labeling efficiency (80%
for all the cysteine proteins). Similar results were obtained with
the fluorescent dye NBD (supplemental Fig. 1, C andD). These
results show that each of the proOmpA-DHFR proteins is
labeled efficiently with a fluorophore at specific cysteine posi-
tions. In particular with NBD and to a lesser extent with OG,
position-specific differences in fluorescence intensity were
observed between the proOmpA-DHFR proteins in the gel,
whereas the same amount of protein was loaded (supplemental
Fig. 1, A–D), and the same extent of labeling was obtained as
verified by absorbance measurements. This indicates that in
particular NBD is responsive to the local environment of the
polypeptide chain in the gel.
Generation of Fluorescent Translocation Intermediates—The
fluorescently labeled proOmpA-DHFRproteinswere subjected
to translocation experiments, using a protease protection assay.
In this assay, preproteins translocated into the IMVs become
protected against digestion from externally added protease.
Because of the presence of a fluorophore, translocated proteins
can be visualized directly in gel after SDS-PAGE. When
proOmpA-DHFR was first unfolded in urea and subsequently
diluted into translocation buffer, the protein was completely
translocated in the presence of ATP, yielding protease-pro-
tected proOmpA-DHFR at the expected position in the gel, i.e.
58 kDa for the cysteine proteins (Fig. 2A). However, when the
DHFRmoiety first was allowed to fold by pre-dilution and incu-
bation in a buffer containing SecB and the folding ligands
NADPH and methotrexate, it becomes too large to pass the
channel and will not translocate to its full length. Under those
conditions, the folded DHFR has the additional property that it
becomes protease-resistant, and only the junction between
proOmpAand foldedDHFR is partially protease-accessible (37,
38). Therefore, a proOmpA-DHFR translocation intermediate
yields two protein bands on a gel after protease digestion, i.e. at
the position of the full-length proOmpA-DHFR preprotein (58
kDa) and as protected proOmpA (37 kDa, I37) (Fig. 2C) (37).
With all fluorescent proOmpA-DHFR proteins, the level of
translocation intermediate formationwas similar, showing that
the presence of the label at the different positions does not
dramatically alter the translocation efficiency (Fig. 2, C and D).
Next, the conditions resulting in the formation of the fluo-
rescent translocation intermediates were analyzed in more
detail. The translocation intermediate was observed only after
energizing the system with ATP and not when ADP or AMP-
PNP, a nonhydrolyzable ATP analog, were added (Fig. 2E, lanes
2 and 3). The amount of translocation intermediate depended
on the level of SecYEG expression in the membranes, with sig-
nificantly higher levels observed with membranes containing
overproduced SecYEG as compared with wild-type IMVs (Fig.
2E, compare lanes 1 and 4). To show that the full-length
proOmpA-DHFR protease-protected band (Fig. 2, C and E,
lane 1) represents a true translocation intermediate, the pre-
protein was forced to shift to other intermediate positions.
Here, the DHFR domain was first unfolded by removing the
folding ligands by means of a centrifugation step through a
sucrose cushion (37). Next, the sample was subjected to ther-
mal incubation at 37 °C and mechanically sheared by bath son-
ication, whereupon the IMVs were protease-treated and ana-
lyzed by SDS-PAGE. This treatment resulted in reduced
amounts of full-length proOmpA-DHFR and increased levels
of proOmpA andOmpA (Fig. 3, lane 5). In addition, distinctive
protease-resistant bands appeared that were smaller and larger
than proOmpA (Fig. 3) and that were previously indicated as
the intermediates I26 (13) and I40 (37) These data suggest that
in the absence of ATP and upon unfolding of theDHFRmoiety,
the proOmpA-DHFR intermediate canmove in positionwithin
FIGURE 1. Outline of the proOmpA-DHFR fusion constructs. The signal
sequence (SS), OmpA, and DHFR moieties are indicated, as well as the posi-
tions of the unique cysteines. The -barrel and C-terminal periplasmic
domains of OmpA are indicated separately. Numbering of the residues is
without the signal sequence for consistency. The positions that tested posi-
tive () and negative () in a cross-link analysis with SecY and the I37 trans-
location intermediate are indicated (37).
FIGURE2.Translocationandproteaseprotectionof fluorescently labeled
proOmpA-DHFR. Translocation of urea-denatured (A) and prefolded OG-la-
beled proOmpA-DHFR (C). Lanes 1–8, 80% of the protease K-treated sample.
B and D, 10% of nonprotease-digested sample as a standard of the reactions
shown in A and C. E, nucleotide and SecYEG dependence of the formation of
the proOmpA(Cys301)-DHFR-OG fluorescent translocation intermediate.
Lanes 1–6, 80% of the protease-treated sample, and lane 7, 10% of nondi-
gested sample as a standard.
SecYEG Channel Polarity
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the channel. Taken together, these results demonstrate the effi-
cient generation of fluorescently modified translocation inter-
mediates of proOmpA-DHFR in IMVs of E. coli.
Solvation of Translocation Intermediates—The polarity-sen-
sitive fluorophore NBD has appreciable fluorescence only in a
hydrophobic environment and is almost completely quenched
in aqueous solution (45, 46). With all NBD-labeled proOmpA-
DHFR proteins, the fluorophore was quenched to background
levels when the protein was diluted from urea into an aqueous
buffer, both in the presence and absence of SecB (Fig. 4 showing
proOmpA(Cys301)-DHFR). Apparently, with none of the posi-
tions, the binding of the proOmpAmoiety to SecB resulted in a
shielding of NBD from the solvent, consistent with the notion
that SecB binds only to the -barrel domain of proOmpA and
not to the C terminus (47). The NBD fluorescence increased
7-fold when the protein was diluted into the apolar solvent
(99%) ethanol (Fig. 4). These results show that NBD is a sensi-
tive reporter of the polarity of the environment when conju-
gated to the proOmpA-DHFR preprotein, and that the change
of fluorescence intensity can be used as a measure to assess
the polarity of the environment.
To analyze the solvation state of the various positions of the
PCC-entrapped proOmpA-DHFR translocation intermediate,
NBD-labeled proteins were subjected to a translocation exper-
iment. For this purpose, first the translocation of NBD-labeled
proOmpA(Cys302) was followed in time in the absence or pres-
ence of the folding ligands methotrexate and NADPH. When
translocation was initiated with ATP, no change in NBD fluo-
rescence was observed when the unfolded proOmpA-DHFR
was used as a substrate (Fig. 5D, line 4). On the other hand, with
the methotrexate/NADPH-stabilized proOmpA-DHFR, a sub-
stantial NBD fluorescence increase was observed (Fig. 5D, line
1), whereas no change was detectable when ATP was replaced
for ADP (line 2) or the nonhydrolyzable ATP analogAMP-PNP
(line 3). These data demonstrate that the accumulation of a
stable translocation intermediate can be detected fluorescently
with NBD and that trapping of the protein results in a altered
environment of the NBD probe at position 302. In contrast,
when conditions are used that lead to complete translocation,
no fluorescence change is observed showing that the fluores-
cence changes are not because of pre- or post-translocation
folding or unfolding.
Next, the NBD fluorescence was recorded before and after
the formation of a translocation intermediate labeled at differ-
ent positions with NBD, and nonsaturating preprotein
amounts were used so that the intermediate levels increased
linearly with the amount of preprotein added (data not shown).
Therefore, the emission intensity change can be normalized
relative to the fluorescence intensity of the proOmpA-DHFR
preprotein before translocation. The majority of the NBD con-
jugates tested remained quenched and thus solvent-accessible
in the intermediate state (Fig. 5A). Again position 302 showed a
FIGURE 3. Formation of fluorescently labeled proOmpA-DHFR transloca-
tion intermediates.UnfoldingofDHFR causes retrogrademovements of the
proOmpA-DHFR translocation intermediate in the PCC. Reactions were per-
formedwith proOmpA(C66)-DHFR labeledwith fluorescein. Lane 1, 10%non-
protease-digested proOmpA-DHFR as a standard; lane 2, completely translo-
catedproOmpA-DHFRwith theurea-denaturedDHFRmoiety in thepresence
of ATP; lane 3, a nonenergized reaction in presence of ADP; lane 4, the stand-
ard translocation intermediate with the folded DHFR moiety formed in the
presence of ATP; lane 5, the agitated translocation intermediate. The IMVs
containing the translocation intermediate shown in lane 4were re-isolatedby
sucrose cushion centrifugation to remove the folding ligands methotrexate
and NADPH and ATP and subsequently incubated at 37 °C and bath-soni-
cated to induce retrogade translocation. Except for the 10% standard, all
other samples were protease-treated to visualize the translocated prepro-
tein, and 80% of translocation reaction was loaded. I26 and I40 denote trans-
location intermediates previously described (13, 36). The images shownwere
recorded with a Lumi-imager F1, using a bandpass filter at 520 nm.
FIGURE4.EmissionspectraofproOmpA(Cys301)-DHFR-NBD insolventsof
different polarity. Labeled protein was diluted 1:150 in translocation buffer
without (SecB) and with SecB (SecB) and into absolute ethanol (EtOH).
Spectra were equilibrated for 10 min and collected at 37 °C. Spectra were
corrected for background using the cysteine-less proOmpA-DHFR protein.
Monochromators were set at 475 and 525 nm for excitation and emission
wavelengths, respectively.
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significant increase in fluorescence intensity after the forma-
tion of the translocation intermediate (Fig. 5A). To analyze this
region in more detail, additional cysteine substitutions were
introduced at flanking positions, i.e. I300C, D301C, and L303C,
to cover at least the complete turn of a putative -helical
structure. The NBD fluorescence of these positions also
increased upon formation of the intermediates (Fig. 5A). The
emission maximum of NBD was blue-shifted (Fig. 5C show-
ing proOmpA(Cys301)-DHFR-NBD), demonstrating that
NBD is transferred from a polar to a more hydrophobic envi-
ronment upon the formation of the translocation intermedi-
ates. The increase in NBD fluorescence intensity was observed
only under energized conditions, i.e. with ATP and not with
ADP or AMP-PNP (Fig. 5B). When the IMVs bearing overex-
pressed levels of SecYEG were replaced for wild-type mem-
branes, the detection was too insensitive to reveal significant
changes in fluorescence (Fig. 5B).
Under these conditions, only low
levels of intermediate were formed
(Fig. 2E). Taken together, these data
demonstrate that the positions
300–303 of proOmpA-DHFR expe-
rience a change in solvation upon
formation of the translocation
intermediates. This change corre-
sponds to an increased hydropho-
bicity of the environment.
Localization of Translocation
Intermediates—To determine the
position of the aminoacyl residues
of the proOmpA-DHFR transloca-
tion intermediates within the PCC,
an oxidative cross-link approach
was employed. Previously, a ribo-
some-bound proOmpA transloca-
tion intermediate could be cross-
linked to both the pore and the plug
domains (27). Therefore, a SecY
mutant was used with a cysteine at
position 67 (F67C) in the plug and
one with a cysteine at position 282
(S282C) just below the pore. These
mutants supported the formation
of proOmpA-DHFR translocation
intermediates with similar effi-
ciency as with wild-type SecYEG
(data not shown). An efficient cross-
link between proOmpA-DHFR and
the F67C mutant was observed for
positions 300–303 (Fig. 6 showing
proOmpA(Cys302)-DHFR). The cross-
linked product, which migrated at a
position in SDS-PAGE correspond-
ing to amolecularmass of about 125
kDa, was identified with both anti-
SecY (Fig. 6,A, lane 6, and B, lanes 2
and 4) and anti-proOmpA antibod-
ies (Fig. 6C, lane 5). Cross-linking
was not observed under reducing conditions (Fig. 6, B, lane 1,
and C, lane 1) or when no translocation intermediate was
formed, i.e.whenATPwas omitted (Fig. 6,B, lane 5, andC, lane
4). Because the F67C mutant still contained the endogenous
cysteines at positions 329 and 385, a control reaction was per-
formed with IMVs containing overproduced levels of wild-type
SecYEG. With those membranes, no cross-linked products
were formed (Fig. 6B, lane 3). A lower efficiency of cross-linking
occurred between the proOmpA-DHFR proteins with a unique
cysteine at positions 300–303 and Cys282 of SecY (see Fig. 6C,
lanes 1 and 2). In the gels, an anti-proOmpA IgG-reactive pro-
tein band was observed that was not present when proOmpA-
DHFR was reduced. This band corresponds to the oxidized
dimeric form of proOmpA-DHFR. Taken together, these data
suggest that positions 300–303 of the proOmpA-DHFR trans-
location intermediate localize near the plug of SecY.
FIGURE 5. ProOmpA-DHFR translocation intermediates encounter a hydrophobic region in the PCC.
A, NBD fluorescencechangeupon the formationof aproOmpA-DHFR translocation intermediate labeledat the
indicated positions with the NBD probe. Shown is the difference of the emission before and after addition of
ATP expressed as normalized fluorescence F/F0, after subtraction of the cysteine-less signal. B, nucleotide and
SecYEGdependence of theNBD fluorescence change upon the formation of the proOmpA(Cys301)-DHFR-NBD
fluorescent translocation intermediate. IMVs containing overexpressed levels of SecYEG were used, unless
indicated otherwise. Where indicated, IMVs containing wild-type levels of SecYEG (wt IMVs) were used, or the
IMVs were omitted (IMVs). C, emission spectra of proOmpA(Cys301)-DHFR-NBD before (ATP) and after
(ATP) the formation of the translocation intermediate. Spectra were corrected for background using the
cysteine-less proOmpA-DHFR translocation intermediate. Monochromators were set at 475 and 525 nm for
excitation and emission wavelengths, respectively. D, time traces of the translocation of NBD-labeled
proOmpA(Cys302)-DHFR in the absence (line 4) or presence (lines 1–3) of the folding ligandsmethotrexate and
NADPH into SecYEG IMVs. Translocation was initiated at the arrow by the addition of ATP (lines 1 and 4), ADP
(line 2), or the nonhydrolyzable ATP analog AMP-PNP (line 3).
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DISCUSSION
In this study, we have employed proOmpA-DHFR transloca-
tion intermediates to probe the polarity of the interior of the
PCC. For this purpose, a cysteine-less proOmpA-DHFR deriv-
ative was used as a template to introduce unique cysteines into
theC-terminal region of proOmpA. Bymeans of a cross-linking
approach, this region was shown previously to be in proximity
to SecY and SecA when present as a translocation intermediate
(38). By the use of thiol chemistry, we have introduced the
polarity-sensitive fluorophore NBD at defined positions into
the proOmpA-DHFR protein. Because the fluorescence char-
acteristics of this probe are highly sensitive to the polarity of the
environment, NBD has been applied successfully to identify
water-accessible regions of proteins (46). ProOmpA is a widely
used substrate for protein translocation studies, and the protein
can be covalently modified with bulky fluorophores (44) or
cross-linkers (27) without obstructing translocation. Indeed,
the introduction of the NBD fluorophore into proOmpA-
DHFR did not affect the translocation ability of the preprotein.
The fluorescence intensity of the NBD fluorophore is
responsive to solvation changes of the fluorophore (45). When
the proOmpA-DHFR proteins were trapped in the PCC as
translocation intermediates, a significant increase in fluores-
cence occurred when NBD was conjugated to unique cysteine
positions 300–303 in the C-terminal domain of proOmpA but
not with up- and downstream positions. The NBD fluorophore
was almost quenched when the proOmpA-DHFR protein was
present in solution, either bound or unbound to SecB, as the
signal was barely further reduced by the presence of 40mMKI.3
With the formation of the translocation intermediate, the flu-
orescence increased up to 1.6-fold for NBD conjugated to the
Cys301. Concomitantly, a blue shift in the emission maximum
was observed. In 99% ethanol, the fluorescence increase of
NBD-labeled proOmpA-DHFR was 7-fold relative to aqueous
buffer, whereas an up to 12-fold increase has been reported for
NBD in the lipid bilayer (46) or 100% ethanol (45). The fluores-
cence increase, however, is not linear with the hydrophobicity
of the environment. The efficiency of the formation of translo-
cation intermediates is about 20% for the total added
proOmpA-DHFR. Therefore, the recalculated fluorescence
increase for the active fraction is about 4-fold. This implies that
NBD bound to proOmpA(Cys301)-DHFR encounters a signifi-
cant hydrophobic environment inside the PCC, which corre-
sponds to about 80% ethanol (45). The hydrophobic region
encountered is at least four consecutive amino acids long but
cannot be defined more precisely as the polypeptide chain is
likely not completely immobilized as translocation intermedi-
ates can move in the pore (11). The secondary structure of the
trapped segment is not known, but our data clearly demon-
strate that the Cys300–Cys303 segment of the proOmpA-DHFR
intermediate is surrounded by a hydrophobic environment of
the PCC.
To determine the location of the Cys300–Cys303 segment of
the proOmpA-DHFR inside the PCC, we use an oxidative
cross-linking method. A relatively strong cross-link could be
demonstrated between Cys302 of proOmpA-DHFR and a cys-
teine at position 67 of SecY. This position is part of TM2a, the
re-entrance loop that has been proposed to function as a plug at
the periplasmic face of the membrane (20). This mutant is also
known as PrlA3, which is one of weaker Prl mutants that sup-
presses signal sequence defects in preproteins (48). Oxidative
cross-link studies have shown that the plugmoves toward SecE
at the periplasmic membrane interface (21, 23). However, a
recent molecular dynamics simulation suggest that the plug
may not be nearly as far displaced upon protein translocation
and remains near the channel center (28). In this respect, when
NBD is directly conjugated to Cys67, it records a highly hydro-
phobic environment, whereas it becomes partially quenched
upon the insertion of a translocation intermediate.3 This indi-
cates that the plug normally localizes to the hydrophobic envi-
ronment of the pore and becomes more water-accessible in the
open state.
3 R. Bol and A. J. M. Driessen, unpublished results.
FIGURE 6. Positional mapping of proOmpA-DHFR translocation interme-
diates. A, oxidative cross-link of various proOmpA-DHFR proteins to
SecY(F67C)EG. After formation of the translocation intermediate, samples
were oxidized with 0.5 mM sodium tetrathionate and incubated for 30min at
37 °C. Samples were analyzed by SDS-PAGE and Western blotting with anti-
SecY antibodies. B, nucleotide and SecYEG dependence of the formation of
an oxidative cross-link between proOmpA(Cys302)-DHFR and SecY(F67C)EG
(F67C IMVs). After formation of the translocation intermediate, samples
were oxidized (ox) with 0.5mM sodium tetrathionate or reduced (red) with 10
mM DTT and incubated for 30 min at 37 °C. Western blots were developed
with anti-SecY antibodies. Where indicated (SecYEG IMVs) IMVs containing
overexpressed levels of SecYEG were used. The asterisk denotes a cross-re-
acted product that corresponds to a disulfide-bonded dimer of proOmpA-
DHFR. C, nucleotide dependence of the formation of an oxidative cross-link
between proOmpA(Cys302)-DHFR and SecY(F67C)EG (F67C IMVs) and
SecY(S282C)EG (S282C IMVs). After incubation in the presence of ATP or
ADP, samples were oxidized (ox) with 0.5 mM sodium-tetrathionate or
reduced (red) with 10 mM DTT and incubated for 30 min at 37 °C. Western
blots were developed with anti-OmpA antibodies. The asterisk denotes the
disulfide-bonded dimer of proOmpA-DHFR.
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In a previous study on the polarity of the PCC, using ribo-
some-bound nascent preproteins labeled with NBD that were
translocated into microsomes, it was concluded that the Sec61
translocon forms an entirely water-filled channel (29, 31),
which is sealed at the trans side by BiP and at the cis side by the
ribosome (30, 32–34). Our data confirm that most of the posi-
tions along thePCC-entrappedproOmpA-DHFR translocation
intermediate are indeed accessible to water. However, a
polypeptide segment around position 302 of the proOmpA-
DHFR intermediate encounters a hydrophobic patch thatmaps
to the plug near the central region of the channel (Fig. 7B). This
is consistent with structural information showing that the pore
and plug domains are hydrophobic entities of the translocation
channel. Yet studies show that the PCC remains active in vitro
evenwhen the plug domain is fixed into a permanent open state
through cross-linking (23) or even by complete removal (24,
25). However, recent studies suggest that in the absence of the
plug domain other loops substitute for the plug (26) suggesting
a more pivotal role of the plug region in sealing the channel for
unwanted ion leaks. Strikingly, in the presence of a transloca-
tion intermediate, a SecY-dependent anion-selective ion leak
has been observed in vitro (49), suggesting that even under
translocation conditions the seal may not be complete. It
should be emphasized, however, that under normal transloca-
tion conditions, channel opening will only be a transient event,
and the ion leak may not be as extensive as with a stable trans-
location intermediate (49). Most likely, under idle conditions,
the hydrophobic pore suffices to impose a seal in the channel,
whereas the plug may play a role as an adjustable flap that pro-
tects the unfolded polypeptide chain for periplasmic proteases
or as a folding catalyst when the polypeptide emerges from the
channel exit into the periplasm. Other subunits of the translo-
case may contribute to sealing the channel for ions at the trans
side, but this remains to be investigated.
The positions 298–303 of proOmpA include a short hydro-
phobic segment in the C terminus (Fig. 7A). Even more pro-
nounced segments (Fig. 7A, H1 and H2) tend to stall the pre-
protein in the channel during
translocation at low ATP concen-
tration or when translocation is
physically blocked, resulting in the
accumulation of specific transloca-
tion intermediates (11, 13, 50, 51).
These segments typically have a
hydrophobicity below that of a
stop-transfer sequence (50, 52).
Transient interactions of such
hydrophobic segments with the
central hydrophobic pore of the
PCC may thus result in the pre-
ferred accumulation of transloca-
tion intermediates. The Cys298–
Cys303 segment of proOmpA,which
we term H3 region, also shows an
above average hydrophobicity, and
this may contribute to a stable
anchoring of the proOmpA-DHFR
intermediate in the central hydro-
phobic region of the PCC.
In conclusion, our studies demonstrate that the active PCC,
containing a preprotein substrate, does not form a continuous
water-filled pathway. It contains a hydrophobic patch in the
central region that contacts preproteins during membrane
transit. These observations lend further support for the hypoth-
esis that the ion seal during translocation is provided by a tight
alignment of the translocating polypeptide with the central
hydrophobic constriction of the channel.
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SUPPLEMENTARY MATERIAL 
 
Fig. 1S. Purification and fluorescent labeling of proOmpA-DHFR proteins. A and B, labeling of 
proOmpA-DHFR with Oregon Green 488 maleimide (OG). C and D, labeling of proOmpA-DHFR with 
N-((2-(iodoacetoxy)ethyl)-N-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole (NBD). Fluorescent imaging 
(A, C) and Coomassie Brilliant Blue R-250 staining (B, D) of the proOmpA-DHFR proteins. For 
fluorescent imaging, a band-pass filter at 520 nm was used with exposures for 100 ms (A) and 1.5 s (C). 
In all lanes, 0.5 µg of protein was loaded. 
 
 
